[Interdisciplinary consensus to management of lupus nephritis in Germany].
In October 2006 a German ad hoc committee consisting of rheumatologists and nephrologists developed a consensus statement on the current practice in the management of lupus nephritis. The published results are summarized.
de Groot
K
K
Medizinische Klinik III, Klinikum Offenbach GmbH, Starkenburgring 66, 63069, Offenbach/Main, Germany. kirsten@de-groot.de
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000175:diagnosis / Q000188:drug therapy*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D009173:Mycophenolic Acid; D001379:Azathioprine; D011241:Prednisone